Cullen Investment Group’s Gilead Sciences GILD Stock Holding History

Cullen Investment Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Buy	12,730 +39	+0.3%	+$5.14K	0.19%	86
2026 Q1	$1.77M	Sell	12,691 -169	-1%	-$23.7K	0.23%	78
2025 Q4	$1.56M	Sell	12,860 -197	-2%	-$23.9K	0.2%	83
2025 Q3	$1.47M	Sell	13,057 -940	-7%	-$107K	0.19%	82
2025 Q2	$1.55M	Sell	13,997 -581	-4%	-$61.8K	0.22%	81
2025 Q1	$1.63M	Sell	14,578 -1,230	-8%	-$127K	0.25%	76
2024 Q4	$1.46M	Sell	15,808 -515	-3%	-$46.4K	0.22%	80
2024 Q3	$1.37M	Sell	16,323 -1,151	-7%	-$87.8K	0.2%	87
2024 Q2	$1.2M	Sell	17,474 -1,167	-6%	-$77.9K	0.19%	90
2024 Q1	$1.34M	Sell	18,641 -1,243	-6%	-$95.6K	0.21%	91
2023 Q4	$1.61M	Buy	+19,884	New	+$1.55M	0.28%	75

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cullen Investment Group's GILD Position: Q2 2026 in Review

Cullen Investment Group increased its Gilead Sciences (GILD) stake by 0.31% in Q2 2026, buying an estimated $5.14K and bringing the position to 12,730 shares worth $1.61M. The position accounts for 0.19% of the portfolio, ranked #86.

Cullen Investment Group first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.77M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Cullen Investment Group held 12,730 shares of Gilead Sciences worth $1.61M as of Q2 2026.
Cullen Investment Group bought 39 Gilead Sciences shares in Q2 2026, an estimated $5.14K.
Gilead Sciences made up 0.19% of Cullen Investment Group's portfolio in Q2 2026, its #86 holding.
Cullen Investment Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
Cullen Investment Group's Gilead Sciences position peaked at $1.77M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cullen Investment Group's 13F filing for Q2 2026, filed 9 Jul 2026.